Status:
RECRUITING
Development of a New Method for Liver Stiffness Measurement Using FibroScan
Lead Sponsor:
Echosens
Conditions:
Liver Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a n...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
- Adult patient able to give his written consent
- Patient affiliated to the French Social Security system
Exclusion
- Vulnerable patients
- Patients with liver ascites
- Patients with heart failure
Key Trial Info
Start Date :
November 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT06519331
Start Date
November 8 2024
End Date
May 31 2027
Last Update
August 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Nord Essonne - Site Paris- Saclay
Orsay, France, 91400
2
Hôpital Pitié-Salpêtrière
Paris, Île-de-France Region, France, 75013